711 related articles for article (PubMed ID: 11713532)
1. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.
Yang Z; Zhu Q; Luo K; Zhou Q
Nature; 2001 Nov; 414(6861):317-22. PubMed ID: 11713532
[TBL] [Abstract][Full Text] [Related]
2. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.
Nguyen VT; Kiss T; Michels AA; Bensaude O
Nature; 2001 Nov; 414(6861):322-5. PubMed ID: 11713533
[TBL] [Abstract][Full Text] [Related]
3. MAQ1 and 7SK RNA interact with CDK9/cyclin T complexes in a transcription-dependent manner.
Michels AA; Nguyen VT; Fraldi A; Labas V; Edwards M; Bonnet F; Lania L; Bensaude O
Mol Cell Biol; 2003 Jul; 23(14):4859-69. PubMed ID: 12832472
[TBL] [Abstract][Full Text] [Related]
4. Controlling cellular P-TEFb activity by the HIV-1 transcriptional transactivator Tat.
Muniz L; Egloff S; Ughy B; Jády BE; Kiss T
PLoS Pathog; 2010 Oct; 6(10):e1001152. PubMed ID: 20976203
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA.
Chen R; Yang Z; Zhou Q
J Biol Chem; 2004 Feb; 279(6):4153-60. PubMed ID: 14627702
[TBL] [Abstract][Full Text] [Related]
6. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
7. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription.
Barboric M; Yik JH; Czudnochowski N; Yang Z; Chen R; Contreras X; Geyer M; Matija Peterlin B; Zhou Q
Nucleic Acids Res; 2007; 35(6):2003-12. PubMed ID: 17341462
[TBL] [Abstract][Full Text] [Related]
8. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.
Garber ME; Mayall TP; Suess EM; Meisenhelder J; Thompson NE; Jones KA
Mol Cell Biol; 2000 Sep; 20(18):6958-69. PubMed ID: 10958691
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
[TBL] [Abstract][Full Text] [Related]
10. Relief of two built-In autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter.
Fong YW; Zhou Q
Mol Cell Biol; 2000 Aug; 20(16):5897-907. PubMed ID: 10913173
[TBL] [Abstract][Full Text] [Related]
11. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor.
Michels AA; Fraldi A; Li Q; Adamson TE; Bonnet F; Nguyen VT; Sedore SC; Price JP; Price DH; Lania L; Bensaude O
EMBO J; 2004 Jul; 23(13):2608-19. PubMed ID: 15201869
[TBL] [Abstract][Full Text] [Related]
12. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
Zhou Q; Chen D; Pierstorff E; Luo K
EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
[TBL] [Abstract][Full Text] [Related]
13. A human immunodeficiency virus type 1 Tat-like arginine-rich RNA-binding domain is essential for HEXIM1 to inhibit RNA polymerase II transcription through 7SK snRNA-mediated inactivation of P-TEFb.
Yik JH; Chen R; Pezda AC; Samford CS; Zhou Q
Mol Cell Biol; 2004 Jun; 24(12):5094-105. PubMed ID: 15169877
[TBL] [Abstract][Full Text] [Related]
14. Tat activates human immunodeficiency virus type 1 transcriptional elongation independent of TFIIH kinase.
Chen D; Zhou Q
Mol Cell Biol; 1999 Apr; 19(4):2863-71. PubMed ID: 10082552
[TBL] [Abstract][Full Text] [Related]
15. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
[TBL] [Abstract][Full Text] [Related]
16. Human and rodent transcription elongation factor P-TEFb: interactions with human immunodeficiency virus type 1 tat and carboxy-terminal domain substrate.
Ramanathan Y; Reza SM; Young TM; Mathews MB; Pe'ery T
J Virol; 1999 Jul; 73(7):5448-58. PubMed ID: 10364292
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
Isel C; Karn J
J Mol Biol; 1999 Jul; 290(5):929-41. PubMed ID: 10438593
[TBL] [Abstract][Full Text] [Related]
18. Acetylation of cyclin T1 regulates the equilibrium between active and inactive P-TEFb in cells.
Cho S; Schroeder S; Kaehlcke K; Kwon HS; Pedal A; Herker E; Schnoelzer M; Ott M
EMBO J; 2009 May; 28(10):1407-17. PubMed ID: 19387490
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
20. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
